Stock FAB FUSION ANTIBODIES PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Fusion Antibodies plc

Equities

FAB

GB00BDQZGK16

Market Closed - London S.E.
Other stock markets
 11:35:19 2024-06-26 EDT 		5-day change 1st Jan Change
3.15 GBX -1.56% Intraday chart for Fusion Antibodies plc -8.70% -25.88%
05-23 Celadon ships to US; Oxford BioDynamics-Goodbody pact AN
05-23 Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Celadon ships to US; Oxford BioDynamics-Goodbody pact
AN
Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic
CI
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue
AN
Fusion Antibodies inks commercial contract for OptiPhage library
AN
Fusion Antibodies Secures Contract to Set Up OptiPhage Library
MT
Fusion Antibodies plc Enters into Commercial Contract to Develop a Bespoke OptiPhageTM Library
CI
Sondrel wins USD23 million contract
AN
Fusion Antibodies Lands Antibodies Contract with Diagnostics Company
MT
Fusion Antibodies plc Receives First Purchase Order Under the Master Services Agreement
CI
Fusion Antibodies raises GBP1.4 million via placing
AN
Fusion Antibodies strikes follow-on research and development project
AN
Fusion Antibodies Receives Follow-On Project from US Biotechnology Client
MT
AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations
AN
Fusion Antibodies plc Receives Follow-On Project Award and R&D Update
CI
Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform
AN
Fusion Antibodies shares fall with revenue despite "positive" outlook
AN
Fusion Antibodies plc Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Fusion Antibodies plc Provides Revenue Guidance for the Fiscal Year 2024
CI
Fusion Antibodies shares up on deal with US National Cancer Institute
AN
Fusion Antibodies plc Announces That It Has Signed Collaboration Agreement with the National Cancer Institute for the Use of Optimal
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FAB Stock
  4. News Fusion Antibodies plc
  5. Highlights